These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26769851)

  • 1. Inhibition of breast cancer cell motility with a non-cyclooxygenase inhibitory derivative of sulindac by suppressing TGFβ/miR-21 signaling.
    Yi B; Chang H; Ma R; Feng X; Li W; Piazza GA; Xi Y
    Oncotarget; 2016 Feb; 7(7):7979-92. PubMed ID: 26769851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel COX-independent mechanism of sulindac sulfide involves cleavage of epithelial cell adhesion molecule protein.
    Liggett JL; Min KW; Smolensky D; Baek SJ
    Exp Cell Res; 2014 Aug; 326(1):1-9. PubMed ID: 24859349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats.
    Tinsley HN; Mathew B; Chen X; Maxuitenko YY; Li N; Lowe WM; Whitt JD; Zhang W; Gary BD; Keeton AB; Grizzle WE; Grubbs CJ; Reynolds RC; Piazza GA
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel sulindac derivative inhibits lung adenocarcinoma cell growth through suppression of Akt/mTOR signaling and induction of autophagy.
    Gurpinar E; Grizzle WE; Shacka JJ; Mader BJ; Li N; Piazza NA; Russo S; Keeton AB; Piazza GA
    Mol Cancer Ther; 2013 May; 12(5):663-74. PubMed ID: 23443799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G.
    Tinsley HN; Gary BD; Keeton AB; Zhang W; Abadi AH; Reynolds RC; Piazza GA
    Mol Cancer Ther; 2009 Dec; 8(12):3331-40. PubMed ID: 19996273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity.
    Piazza GA; Keeton AB; Tinsley HN; Gary BD; Whitt JD; Mathew B; Thaiparambil J; Coward L; Gorman G; Li Y; Sani B; Hobrath JV; Maxuitenko YY; Reynolds RC
    Cancer Prev Res (Phila); 2009 Jun; 2(6):572-80. PubMed ID: 19470791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel sulindac derivative lacking cyclooxygenase-inhibitory activities suppresses carcinogenesis in the transgenic adenocarcinoma of mouse prostate model.
    Zhang Y; Zhang J; Wang L; Quealy E; Gary BD; Reynolds RC; Piazza GA; Lü J
    Cancer Prev Res (Phila); 2010 Jul; 3(7):885-95. PubMed ID: 20587701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines.
    Han EK; Arber N; Yamamoto H; Lim JT; Delohery T; Pamukcu R; Piazza GA; Xing WQ; Weinstein IB
    Breast Cancer Res Treat; 1998 Apr; 48(3):195-203. PubMed ID: 9598866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of PDE5 by sulindac sulfide selectively induces apoptosis and attenuates oncogenic Wnt/β-catenin-mediated transcription in human breast tumor cells.
    Tinsley HN; Gary BD; Keeton AB; Lu W; Li Y; Piazza GA
    Cancer Prev Res (Phila); 2011 Aug; 4(8):1275-84. PubMed ID: 21505183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon tumor cell growth-inhibitory activity of sulindac sulfide and other nonsteroidal anti-inflammatory drugs is associated with phosphodiesterase 5 inhibition.
    Tinsley HN; Gary BD; Thaiparambil J; Li N; Lu W; Li Y; Maxuitenko YY; Keeton AB; Piazza GA
    Cancer Prev Res (Phila); 2010 Oct; 3(10):1303-13. PubMed ID: 20876730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
    He Q; Luo X; Huang Y; Sheikh MS
    Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs.
    Li X; Gao L; Cui Q; Gary BD; Dyess DL; Taylor W; Shevde LA; Samant RS; Dean-Colomb W; Piazza GA; Xi Y
    Oncogene; 2012 Nov; 31(48):4979-86. PubMed ID: 22286762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-inducible miR-191 promotes migration in breast cancer through complex regulation of TGFβ-signaling in hypoxic microenvironment.
    Nagpal N; Ahmad HM; Chameettachal S; Sundar D; Ghosh S; Kulshreshtha R
    Sci Rep; 2015 Apr; 5():9650. PubMed ID: 25867965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.
    Piazza GA; Rahm AL; Krutzsch M; Sperl G; Paranka NS; Gross PH; Brendel K; Burt RW; Alberts DS; Pamukcu R
    Cancer Res; 1995 Jul; 55(14):3110-6. PubMed ID: 7606732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells.
    Lim JT; Joe AK; Suzui M; Shimizu M; Masuda M; Weinstein IB
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3478-84. PubMed ID: 16740773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsteroidal anti-inflammatory drug sulindac sulfide suppresses structural protein Nesprin-2 expression in colorectal cancer cells.
    Liggett JL; Choi CK; Donnell RL; Kihm KD; Kim JS; Min KW; Noegel AA; Baek SJ
    Biochim Biophys Acta; 2014 Jan; 1840(1):322-31. PubMed ID: 24080406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activity.
    Whitt JD; Li N; Tinsley HN; Chen X; Zhang W; Li Y; Gary BD; Keeton AB; Xi Y; Abadi AH; Grizzle WE; Piazza GA
    Cancer Prev Res (Phila); 2012 Jun; 5(6):822-33. PubMed ID: 22556201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncoupling of oxidative phosphorylation and Smac/DIABLO release are not sufficient to account for induction of apoptosis by sulindac sulfide in human colorectal cancer cells.
    Daouphars M; Koufany M; Benani A; Marchal S; Merlin JL; Netter P; Jouzeau JY
    Int J Oncol; 2005 Apr; 26(4):1069-77. PubMed ID: 15754004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cyclooxygenase inhibitor sulindac sulfide inhibits EP4 expression and suppresses the growth of glioblastoma cells.
    Kambe A; Yoshioka H; Kamitani H; Watanabe T; Baek SJ; Eling TE
    Cancer Prev Res (Phila); 2009 Dec; 2(12):1088-99. PubMed ID: 19934343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.
    Piazza GA; Rahm AK; Finn TS; Fryer BH; Li H; Stoumen AL; Pamukcu R; Ahnen DJ
    Cancer Res; 1997 Jun; 57(12):2452-9. PubMed ID: 9192825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.